title: Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors.
abstract: Inhalation of radon is closely associated with an increased risk of lung cancers. While the involvement of Ink4a in lung tumor development has been widely described, the tumor suppressor gene has not been studied in radon-induced lung tumors. In this study, loss of heterozygosity (LOH) analysis of the Cdkn2a locus, common to the Ink4a and Arf genes, was performed on 33 radon-induced rat lung tumors and showed a DNA loss in 50% of cases. The analysis of p16(Ink4a) protein expression by immunohistochemistry revealed that 50% of the tumors were negative for this protein. Looking for the origin of this lack of expression, we observed a low frequency of homozygous deletion (6%), a lack of mutation, an absence of correlation between promoter methylation and Ink4a mRNA expression and no correlation between LOH and protein expression. However, a tendency for an inverse correlation between p16(Ink4a) and pRb protein expression was observed. The expressions of p19Arf, Mmd2 and Mdm4 were not deregulated and only 14% of the tumors were mutated for Tp53. These results indicated that Ink4a/Cdk4/Rb1 pathway deregulation, more than Arf/Mdm2/Tp53 pathway, has a major role in the development of these tumors through p16(Ink4a) deregulation. However, all known mechanisms of inactivation of the pathway do not play a recurrent role in these tumors and the actual origin of the lack of p16(Ink4a) protein expression remains to be established.
authors.affiliation: CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses Cedex F-92265, France. kristell.bastide@cea.fr
authors.forename: Kristell
authors.initials: K
authors.lastname: Bastide
authors.forename: Marie-Noëlle
authors.initials: MN
authors.lastname: Guilly
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bernaudin
authors.forename: Christophe
authors.initials: C
authors.lastname: Joubert
authors.forename: Bruno
authors.initials: B
authors.lastname: Lectard
authors.forename: Céline
authors.initials: C
authors.lastname: Levalois
authors.forename: Bernard
authors.initials: B
authors.lastname: Malfoy
authors.forename: Sylvie
authors.initials: S
authors.lastname: Chevillard
mesh_terms: D000818:Animals; D002274:Carcinogens, Environmental / Q000633:toxicity; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000032:analysis / Q000235:genetics*; D019175:DNA Methylation; D015972:Gene Expression Regulation, Neoplastic; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000139:chemically induced / Q000737:chemistry / Q000235:genetics*; D009154:Mutation; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000737:chemistry / Q000235:genetics; D016133:Polymerase Chain Reaction; D012334:RNA, Neoplasm / Q000032:analysis / Q000235:genetics*; D011886:Radon / Q000633:toxicity; D051381:Rats; D011916:Rats, Inbred F344; D011920:Rats, Inbred WF; D017207:Rats, Sprague-Dawley; D016160:Retinoblastoma Protein / Q000032:analysis / Q000235:genetics*; D025803:Tumor Suppressor Protein p14ARF / Q000032:analysis / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics*
chemical_list: D002274:Carcinogens, Environmental; D019941:Cyclin-Dependent Kinase Inhibitor p16; D012334:RNA, Neoplasm; D016160:Retinoblastoma Protein; D025803:Tumor Suppressor Protein p14ARF; D016159:Tumor Suppressor Protein p53; D011886:Radon